Overcoming cancer drug resistance
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Sep-2025 00:11 ET (9-Sep-2025 04:11 GMT/UTC)
Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in Nature Communications how the targeted suppression of lysosome function may lead to brain cancer therapy.
The use of 5-aminosalicylic acid with ustekinumab shows no significant overall benefits in inflammatory bowel disease. However, post hoc subgroup analyses suggest potential benefits in specific patient groups, emphasizing the importance of tailoring treatment based on individual therapy history.
Fluency in a foreign language is often thought to be about speaking quickly and using advanced vocabulary. However, researchers from Waseda University reveal that speakers who use common, everyday expressions sound more fluent than those who rely on rare, complex words. The study highlights the importance of mastering familiar phrases to improve fluency perception, suggesting that learners should naturally incorporate common formulaic expressions in spontaneous speech.
Nanomedicine is revolutionizing cancer treatment through precise drug delivery and advanced therapies, but clinical translation requires scalable solutions. Researchers in Japan have developed bacteria-enhanced graphene oxide nanoparticles that integrate chemotherapy, photothermal therapy, and immune activation, effectively suppressing tumors in mice. When combined with laser treatment, they achieved complete tumor eradication. This advancement offers a scalable, targeted approach, addressing the limitations of traditional therapies and paving the way for more effective cancer treatments.